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OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model
based on clinical characteristics and the walking impairment questionnaire.
METHODS: The sample included 133 intermittent claudication patients of both genders aged between 30 and
80 years. Data regarding clinical characteristics, the walking impairment questionnaire and treadmill walking
test performance were obtained. Multiple regression modeling was conducted to predict claudication onset
distance and total walking distance using clinical characteristics (age, height, mass, body mass index, ankle
brachial index lower, gender, history of smoking and co-morbid conditions) and walking impairment
questionnaire responses. Comparisons of claudication onset distance and total walking distance measured
during treadmill tests and estimated by a regression equation were performed using paired t-tests.
RESULTS: Co-morbid conditions (diabetes and coronary artery disease) and questions related to difficulty in
walking short distances (walking indoors – such as around your house and walking 5 blocks) and at low speed
(walking 1 block at average speed – usual pace) resulted in the development of new prediction models high
significant for claudication onset distance and total walking distance (p,0.001). In addition, non-significant
differences from the results obtained by the treadmill test and estimated by the current model (p.0.05) were
observed.
CONCLUSION: The current study demonstrated that walking capacity can be adequately estimated based on co-
morbid conditions and responses to the walking impairment questionnaire.
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& INTRODUCTION
Peripheral artery disease affects lower extremity arteries
and reduces oxygen supply to peripheral tissues (1).
Intermittent claudication, the most prevalent symptom of
peripheral artery disease, leads to reduced walking capa-
city, which has been associated with all-cause and cardio-
vascular mortality (2,3), mobility loss (4) and lower
extremity strength (5).
Walking capacity in intermittent claudication patients has
been assessed in research settings with the standardized
treadmill test, which provides the claudication onset
distance and total walking distance (6). On the other hand,
in clinical settings, the treadmill test is not feasible (7), and
other tools to predict walking capacity have been used.
Previous studies have proposed specific equations to
predict walking capacity in intermittent claudication
patients. Gardner et al. (8), validated an equation to predict
walking capacity based on ankle-brachial index, body mass
index and current smoking status. Recently, Leitch et al. (9),
predicted walking capacity with better accuracy using
general questions regarding quality of life in the equation.
The walking impairment questionnaire is a specific ques-
tionnaire for patients with intermittent claudication which has
been used as an alternative tool to assess walking capacity
(10,11). Previous studies have shown that the walking
impairment questionnaire is more strongly correlated with
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walking capacity than the quality of life questionnaire (12,13).
However, whether the walking impairment questionnaire
accurately predicts claudication onset distance and total
walking distance has not been not previously described.
Our hypothesis is that clinical status and walking
impairment questionnaire responses are significant predic-
tors of walking capacity. Therefore, the aim of this study
was to estimate the walking capacity in intermittent
claudication patients through a prediction model based on
clinical characteristics and the walking impairment ques-
tionnaire.
& MATERIAL AND METHODS
Patients
Four hundred forty consecutive patients were recruited at
a tertiary care center that specializes in vascular disease.
Patients with peripheral artery disease and claudication
symptoms were included in this study if they had an ankle-
brachial index #0.90 at rest, no pain at rest, and no evidence
of mental disability identified by the Mini-Mental State
Examination Questionnaire (14) and were willing to
volunteer to participate in the study. A total of 133
intermittent claudication patients were deemed eligible for
the study.
Assessments
Demographic information, height, weight, smoking his-
tory and comorbid conditions (hypertension, dyslipidemia,
diabetes and coronary artery disease) were obtained
through medical history and physical examination. Ankle
and arm blood pressures were assessed, and the ankle-
brachial index was calculated by the quotient of ankle
systolic blood pressure over brachial systolic blood pressure
(15).
Walking capacity on treadmill
The patients performed a graded maximal treadmill test
(model 2200.1 Trimline; Hebb Industries Inc., Whitehouse,
Texas) using a specific protocol for patients with IC as
previously described (6). Briefly, the treadmill speed was
maintained at 2.0 mph, and the treadmill grade was
increased 2% every 2 minutes until the patients could no
longer continue because of claudication symptoms. The
claudication onset distance and the total walking distance
were defined, respectively, as the distance walked when the
patient first reported pain in the leg and the distance at
which the patient was unable to continue to exercise due to
leg pain.
Walking Impairment Questionnaire
The walking impairment questionnaire is composed of 14
items distributed in 4 domains, one including general
information and three regarding walking capacity (distance,
speed and using stairs). Each item is ranked from 0 to 4 on a
Likert scale, in which 0 represents unable to perform and 4
represents no difficulty. These data were obtained through
personal interviews. The Brazilian Portuguese version of the
walking impairment questionnaire has previously been
validated (11).
The distances that are assessed by the walking impair-
ment questionnaire range from walking indoors around the
home to walking 5 blocks outside. The speeds are assessed
as the difficulty of walking 1 block at each of the following
speeds: slowly, average speed, quickly and jogging or
running. Stair use ability is assessed by the difficulty of
climbing up one, two or three flights of stair. We analyzed
the reliability of each question after seven days in a
subsample of 25 patients, and the interclass correlation
coefficient ranged from 0.76 to 0.98.
Statistical Analysis
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS version 10, SPSS Inc., Chicago, Illinois,
USA). Normality was verified by the Kolgomorov-Sminorv
test. Multiple regression modeling was conducted to predict
claudication onset distance and total walking distance from
the independent variables: age, height, mass, body mass
index, the ankle-brachial index of the lower extremities,
gender (male = 1, female = 0), smoking history (yes = 1,
no = 0), co-morbid conditions (hypertension, diabetes, dysli-
pidemia and coronary artery disease; yes = 1, no = 0) and
walking impairment questionnaire responses (0 to 4).
The claudication onset distance and total walking
distance measured during the treadmill test were compared
to the estimated values of claudication onset distance and
total walking distance obtained by the regression model
using paired t-tests. The accuracy of the regression model
was further examined by the absolute error [(absolute
difference between predicted and actual value)/actual value
x 100] and the proportion of predicted values within 10%,
10-25% and .25% of the treadmill result (16). The sig-
nificance level was set at p,0.05 for all analyses.
Ethics
The procedures used in this study were approved by the
Institutional Review Board of the University of Pernambuco
and by the Institutional Review Board of the Hospital of
Clinics of University of Sa˜o Paulo. Written informed consent
was obtained from each patient prior to investigation.
& RESULTS
The characteristics of the sample are shown in Table 1.
Most of the patients were male (64.7%) and non-obese. The
prevalence of co-morbid conditions ranged from 38.6%
(diabetes) to 76.7% (hypertension).
Table 2 displays the responses for each question of the
walking impairment questionnaire: 27.9% of patients
reported being unable to walk 5 blocks, 85.7% reported that
they are not able to jog or run, and 20.3% reported that they
are not able to climb three flights of stairs.
Table 1 - General characteristics of intermittent
claudication patients (n =133).
Variables Values
Age (years) 63.2¡8.8
Body mass index (kg.m-2) 26.4¡4.6
Ankle-brachial index 0.59¡0.15
Gender (% men) 64.7
Smoking history (% yes) 84.2
Hypertension (% yes) 76.7
Dyslipidemia (% yes) 70.7
Diabetes (% yes) 38.3
Coronary artery disease (% yes) 56.4
Values are presented in mean ¡ standard-deviation or frequency.
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Regression analyses indicated that Q1 (walking indoors –
such as around your house), Q4 (walking 1 block) and Q9
(walking 1 block at average speed – usual pace) of the walking
impairment questionnaire, as well as diabetes and coronary
artery disease, were independent predictors of claudication
onset distance and total walking distance (Table 3). Prediction
models resulted in moderate correlation coefficients (claudica-
tion onset distance: r=0.52; total walking distance: r=0.58) and
non-significant differences from the results obtained in tread-
mill test (Estimated by current model: claudication onset
distance 2 175¡81 m and total walking distance 2
408¡173 m; Measured by the treadmill test: claudication onset
distance 2 175¡155 m and total walking distance 2
408¡295 m; p.0.05). In addition, absolute errors less than
25% were found for claudication onset distance (21%) and total
walking distance (32%) (Figure 1).
& DISCUSSION
The current study demonstrated that walking capacity may
be adequately estimated based on co-morbid conditions and
walking impairment questionnaire questions. Inclusion of co-
morbid conditions, such as diabetes and coronary artery
disease, as well as questions related to difficulty in walking
short distances and at low speeds resulted in the development
of new prediction models for walking capacity that are more
accurate than previously published models for patients with
intermittent claudication (8,9).
In the present study, diabetes and coronary artery disease
were independent predictors of walking capacity. Previous
studies have shown that diabetes and coronary artery
disease are related to walking impairment in intermittent
claudication patients (17-20), which has previously been
attributed to respiratory, metabolic and vascular dysfunc-
tion (21,22). In addition, diabetes has been associated with
endothelial dysfunction and increased oxidative stress, pro-
inflammatory status and mitochondrial dysfunction (23).
Coronary artery disease patients also have endothelial
dysfunction and experience reduced cardiorespiratory fit-
ness compared to non-coronary artery disease patients (21).
Although the walking impairment questionnaire has been
widely used to assess walking impairment in intermittent
claudication patients (13,24,25), whether this questionnaire
is able to predict walking capacity has not been previously
analyzed. The results of the present study indicate that the
walking impairment questionnaire predicts walking capa-
city in intermittent claudication patients. Questions related
to difficulty in walking short distances and walking at low
speeds were significantly correlated to claudication onset
distance and total walking distance. Thus, it seems that the
best questions to predict walking capacity are those
indicative of major limitations of the patient.
Interestingly, in the present study, walking impairment
questionnaire questions regarding climbing stairs were not
predictors of walking capacity in peripheral artery disease
patients. Previous studies have observed that the climbing stairs
domain of the walking impairment questionnaire was corre-
lated with walking capacity (11-13). However, these studies
were performed using bivariate analysis, which does not
control for the relationships between the climbing stairs domain
and walking capacity to potential confounders, such as clinical
characteristics or other walking impairment questionnaire
domains.
Poor walking capacity has been associated with increased
risk for all-cause and cardiovascular mortality (2,3), mobility
Table 2 - Frequency of responses on the Walking Impairment Questionnaire in intermittent claudication patients.
Questions Degree of Difficulty
No (%) Slight (%) Some (%) Much (%) Unable (%)
Distance
Q1. Walk indoors (such as around your house) 62.4 16.5 14.3 6.0 0.8
Q2. Walk 5 meters 71.3 12.8 9.8 5.3 0.8
Q3. Walk 45 meters 35.3 21.1 21.8 19.5 2.3
Q4. Walk 90 meters 22.6 15.8 18.0 36.8 6.8
Q5. Walk 180 meters 16.5 7.5 18.1 45.1 12.8
Q6. Walk 270 meters 9.8 10.5 10.5 53.4 15.8
Q7. Walk 450 meters 6.0 4.5 12.0 49.6 27.9
Speed
Q8. Walk 1 block slowly (slower than usual) 38.4 36.8 13.5 10.5 0.8
Q9. Walk 1 block at average speed (usual pace) 11.3 32.3 16.5 33.1 6.8
Q10. Walk 1 block quickly (faster than usual) 4.5 7.5 11.3 40.6 36.1
Q11. Jog or run 1 block 1.5 1.5 1.5 9.8 85.7
Stairs
Q12. Walk up one flights of stairs 38.3 24.8 9.8 25.6 1.5
Q13. Walk up two flights of stairs 23.3 12.0 18.8 37.6 8.3
Q14. Walk up three flights of stairs 12.0 12.0 11.3 44.4 20.3
Table 3 - Prediction model for claudication distance and total walking distance in intermittent claudication patients.
Variables Prediction model r (r2) SEE
CD (m) = 221.535 + (Q4625.351) + (Q1631.484) + (Q9627.146) - (diabetes presence x 47.909)a 0.52 (0.27) 134
TWD (m) = 109.251 + (Q4678.825) + (Q1669.756) - (diabetes presence x 116.255) - (coronary artery
disease presence x 98.725)b
0.58 (0.34) 242
CD – claudication distance; TWD – total walking distance; a F4 = 16.66, p,0.001;
b F4 = 12.07, p,0.001; r - multiple correlation coefficient, r
2 - variance; SEE -
standard estimate of the error; Q – question of Walking Impairment Questionnaire.
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loss (4) and reduced strength in the lower extremities (5). Thus,
the assessment of walking capacity is clinically relevant. The
results of this study showed that walking capacity is adequately
estimated based on clinical characteristics and walking impair-
ment questionnaire questions; this is useful for clinicians to
quantify the walking capacity of intermittent claudication
patients easily.
The present study has some limitations. Walking capacity
was assessed in the graded treadmill test. Therefore, other
ways of assessing walking capacity (e.g., the 6-minute test)
cannot be predicted using the regression models proposed
in this study. The equations for predicting the claudication
onset distance and total walking distance were not cross-
validated in an independent group of similar peripheral
arterial disease patients. This study included only periph-
eral artery disease patients with claudication symptoms,
and the predictive models cannot be extrapolated for
patients with peripheral arterial disease in other stages.
In conclusion, the model based on walking impairment
questionnaire and co-morbid conditions adequately predicted
the walking capacity in intermittent claudication patients.
This information is useful for clinicians to easily quantify the
walking capacity of intermittent claudication patients.
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